Clinicalperspectives and considerations with Retisert® (fluocinolone acetonide intravitreal implant) 0,59 mg in the management of chronic non-infectious uveitis of the posterior segment : expertise beyond the 3-year follow-up clinical trial data : proceedings of an expert panel roundtable discussion - Nguyen, Quan Dong (Lippincott Williams and Wilkins, 2009)
Retina, ISSN 0275-004X Vol. 29, suppl. November/December 2009
Keywords: klinické lékařství; fluocinolonacetonid; zadní uveitida; farmakoterapie; Clinical Medicine; chronická nemoc; Fluocinolone Acetonide; Uveitis, Posterior; oftalmologie; Chronic Disease